These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32697863)

  • 1. Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging.
    Giacomucci G; Monforte M; Diaz-Manera J; Mul K; Fernandez Torrón R; Maggi L; Marini Bettolo C; Dahlqvist JR; Haberlova J; Camaño P; Gros M; Tartaglione T; Cristiano L; Gerevini S; Calandra P; Deidda G; Giardina E; Sacconi S; Straub V; Vissing J; Van Engelen B; Ricci E; Tasca G
    Eur J Neurol; 2020 Dec; 27(12):2604-2615. PubMed ID: 32697863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper girdle imaging in facioscapulohumeral muscular dystrophy.
    Tasca G; Monforte M; Iannaccone E; Laschena F; Ottaviani P; Leoncini E; Boccia S; Galluzzi G; Pelliccioni M; Masciullo M; Frusciante R; Mercuri E; Ricci E
    PLoS One; 2014; 9(6):e100292. PubMed ID: 24932477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2.
    Mair D; Huegens-Penzel M; Kress W; Roth C; Ferbert A
    Eur Neurol; 2017; 77(1-2):32-39. PubMed ID: 27855411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging.
    Monforte M; Laschena F; Ottaviani P; Bagnato MR; Pichiecchio A; Tasca G; Ricci E
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1258-1265. PubMed ID: 31668022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic magnetic resonance imaging biomarkers for facioscapulohumeral muscular dystrophy identified by machine learning.
    Monforte M; Bortolani S; Torchia E; Cristiano L; Laschena F; Tartaglione T; Ricci E; Tasca G
    J Neurol; 2022 Apr; 269(4):2055-2063. PubMed ID: 34486074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
    Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
    Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Skeletal muscle MRI of lower limbs in patients with facioscapulohumeral dystrophy].
    Ma MM; Song J; Zhang JW; Gao L; Pang M; Li G; Fu J
    Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(9):675-679. PubMed ID: 30831616
    [No Abstract]   [Full Text] [Related]  

  • 8. Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles.
    Tasca G; Pescatori M; Monforte M; Mirabella M; Iannaccone E; Frusciante R; Cubeddu T; Laschena F; Ottaviani P; Ricci E
    PLoS One; 2012; 7(6):e38779. PubMed ID: 22719944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study.
    Ragozzino E; Bortolani S; Di Pietro L; Papait A; Parolini O; Monforte M; Tasca G; Ricci E
    Acta Neuropathol Commun; 2023 Oct; 11(1):165. PubMed ID: 37849014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI change metrics of facioscapulohumeral muscular dystrophy: Stir and T1.
    Ferguson MR; Poliachik SL; Budech CB; Gove NE; Carter GT; Wang LH; Miller DG; Shaw DWW; Friedman SD
    Muscle Nerve; 2018 Jun; 57(6):905-912. PubMed ID: 29236297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper body involvement in GNE myopathy assessed by muscle imaging.
    Torchia E; Lucchini M; Bortolani S; Monforte M; Garibaldi M; Mirabella M; Tartaglione T; Ricci E; Tasca G
    Neuromuscul Disord; 2022 May; 32(5):410-418. PubMed ID: 35248449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: Pattern refinement and implications for clinical trials.
    Tasca G; Monforte M; Ottaviani P; Pelliccioni M; Frusciante R; Laschena F; Ricci E
    Ann Neurol; 2016 May; 79(5):854-864. PubMed ID: 26994363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Muscle Testing Compared with Whole-Body Magnetic Resonance Imaging in Facio-scapulo-humeral Muscular Dystrophy.
    Regula JU; Jestaedt L; Jende F; Bartsch A; Meinck HM; Weber MA
    Clin Neuroradiol; 2016 Dec; 26(4):445-455. PubMed ID: 25860436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between muscle inflammation and fat replacement assessed by MRI in facioscapulohumeral muscular dystrophy.
    Dahlqvist JR; Andersen G; Khawajazada T; Vissing C; Thomsen C; Vissing J
    J Neurol; 2019 May; 266(5):1127-1135. PubMed ID: 30778707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report.
    Wang LH; Johnstone LM; Bindschadler M; Tapscott SJ; Friedman SD
    BMC Musculoskelet Disord; 2021 Jan; 22(1):56. PubMed ID: 33422031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative
    Gerhalter T; Marty B; Gast LV; Porzelt K; Heiss R; Uder M; Schwab S; Carlier PG; Nagel AM; Türk M
    J Neurol; 2021 Mar; 268(3):1076-1087. PubMed ID: 33047224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle imaging in facioscapulohumeral muscular dystrophy, pattern and asymmetry of individual muscle involvement.
    Rijken NH; van der Kooi EL; Hendriks JC; van Asseldonk RJ; Padberg GW; Geurts AC; van Engelen BG
    Neuromuscul Disord; 2014 Dec; 24(12):1087-96. PubMed ID: 25176503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach.
    Fatehi F; Salort-Campana E; Le Troter A; Bendahan D; Attarian S
    Rev Neurol (Paris); 2016 Oct; 172(10):566-571. PubMed ID: 27663058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy.
    Tasca G; Monforte M; Corbi M; Granata G; Lucchetti D; Sgambato A; Ricci E
    Mol Neurobiol; 2018 Apr; 55(4):2959-2966. PubMed ID: 28456937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding quantitative muscle MRI to the FSHD clinical trial toolbox.
    Mul K; Vincenten SCC; Voermans NC; Lemmers RJLF; van der Vliet PJ; van der Maarel SM; Padberg GW; Horlings CGC; van Engelen BGM
    Neurology; 2017 Nov; 89(20):2057-2065. PubMed ID: 29030457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.